Studies of Therapy with Thymosin α1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C

• Published in: Annals of the New York Academy of Sciences Vol. 1112; no. 1; pp. 368 - 374
• Main Authors: CAMERINI, ROBERTO, CIANCIO, ALESSIA, DE ROSA, ALFONSO, RIZZETTO, MARIO
• Format: Journal Article
• Language: English
• Published: Malden, USA Blackwell Publishing Inc 01.09.2007
• Subjects: chronic hepatitis C; pegylated interferon; thymosin α1

:  Despite the use of combination therapy with pegylated interferon α2a (peg‐IFN‐α2a) + Ribavirin, a large proportion of patients with chronic hepatitis C (CHC) remain unresponsive to treatment. Thymosin alpha 1 (Tα1) is an immunomodulator, which displays immunological and antiviral activities again...